Identification of TIMELESS and RORA as key clock molecules of non-small cell lung cancer and the comprehensive analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of TIMELESS and RORA as key clock molecules of non-small cell lung cancer and the comprehensive analysis
Authors
Keywords
-
Journal
BMC CANCER
Volume 22, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-25
DOI
10.1186/s12885-022-09203-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Theranostic combinatorial drug-loaded coated cubosomes for enhanced targeting and efficacy against cancer cells
- (2020) Leilei Zhang et al. Cell Death & Disease
- TIMER2.0 for analysis of tumor-infiltrating immune cells
- (2020) Taiwen Li et al. NUCLEIC ACIDS RESEARCH
- Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors Targeting PD(L)1, CTLA-4, and Combination: A Meta-regression Analysis
- (2020) Arsen Osipov et al. CLINICAL CANCER RESEARCH
- Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner
- (2019) Julien N. Bianco et al. Nature Communications
- Emerging Targeted Therapies for the Treatment of Non-small Cell Lung Cancer
- (2019) Patrick R. Halliday et al. Current Oncology Reports
- Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non‐Small Cell Lung Cancer
- (2019) Young Kwang Chae et al. ONCOLOGIST
- Association Between Tumor Mutation Burden (TMB) and Outcomes of Cancer Patients Treated With PD-1/PD-L1 Inhibitions: A Meta-Analysis
- (2019) Jiaxin Zhu et al. Frontiers in Pharmacology
- Circadian Clock Genes and the Transcriptional Architecture of the Clock Mechanism
- (2019) Kimberly H. Cox et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival
- (2018) Bo Li et al. INTERNATIONAL JOURNAL OF CANCER
- Rotating Night Shift work and Colorectal Cancer Risk in the Nurses' Health Studies
- (2018) Kyriaki Papantoniou et al. INTERNATIONAL JOURNAL OF CANCER
- Clock genes, ADHD and aggression
- (2018) Floriana Mogavero et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Night-shift work and breast and prostate cancer risk: updating the evidence from epidemiological studies
- (2018) E. Salamanca-Fernández Anales del Sistema Sanitario De Navarra
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
- (2017) Aaron M. Goodman et al. MOLECULAR CANCER THERAPEUTICS
- Effect of miR-146a-5p on tumor growth in NSCLC using chick chorioallantoic membrane assay and bioinformatics investigation
- (2017) Wen-Ting Huang et al. Molecular Medicine Reports
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Circadian Rhythm Disruption Promotes Lung Tumorigenesis
- (2016) Thales Papagiannakopoulos et al. Cell Metabolism
- Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma
- (2016) Weijing Zhang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Immune Checkpoint Inhibitors in Non‐Small Cell Lung Cancer
- (2016) Benjamin Herzberg et al. ONCOLOGIST
- Nuclear receptor retinoid-related orphan receptor alpha promotes apoptosis but is reduced in human gastric cancer
- (2016) Zhengguang Wang et al. Oncotarget
- miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer
- (2016) Mei Xin et al. Oncotarget
- Clock gene Per2 as a controller of liver carcinogenesis
- (2016) Ali Mteyrek et al. Oncotarget
- Cancer systems biology and modeling: Microscopic scale and multiscale approaches
- (2015) Ali Masoudi-Nejad et al. SEMINARS IN CANCER BIOLOGY
- Association between CLOCK, PER3 and CCRN4L with non-small cell lung cancer in Brazilian patients
- (2014) PATRICIA COUTO et al. Molecular Medicine Reports
- Cancer Systems Biology: a peek into the future of patient care?
- (2014) Henrica M. J. Werner et al. Nature Reviews Clinical Oncology
- Retinoic acid receptor-related receptor alpha (RORalpha) is a prognostic marker for hepatocellular carcinoma
- (2014) Rong-Dang Fu et al. TUMOR BIOLOGY
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- (2013) Balázs Győrffy et al. PLoS One
- TIMELESSis overexpressed in lung cancer and its expression correlates with poor patient survival
- (2012) Kenya Yoshida et al. CANCER SCIENCE
- Blockade of Inflammatory Responses by a Small-Molecule Inhibitor of the Rac Activator DOCK2
- (2012) Akihiko Nishikimi et al. CHEMISTRY & BIOLOGY
- RORα, a Potential Tumor Suppressor and Therapeutic Target of Breast Cancer
- (2012) Jun Du et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma
- (2012) Farhad Azimi et al. JOURNAL OF CLINICAL ONCOLOGY
- Clock Gene Expression Levels and Relationship With Clinical and Pathological Features in Colorectal Cancer Patients
- (2011) G. Mazzoccoli et al. CHRONOBIOLOGY INTERNATIONAL
- Human Timeless and Tipin stabilize replication forks and facilitate sister-chromatid cohesion
- (2010) A. R. Leman et al. JOURNAL OF CELL SCIENCE
- Circadian Disruption in Experimental Cancer Processes
- (2009) Elisabeth Filipski et al. INTEGRATIVE CANCER THERAPIES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started